Home > From Drugnet Europe.

Moore, Joan (2012) From Drugnet Europe. Drugnet Ireland, Issue 41, Spring 2012, p. 26.

[img] PDF (Drugnet Ireland issue 41) - Published Version

Best practice portal: bridging the gap
Article by Marina Davili and Marica Ferri in Drugnet Europe, No. 77, January–March 2012  

One of the added values of the EMCDDA’s Best practice portal(www.emcdda.europa.eu/best-practice) is the synthesis of available evidence on the effects of drug demand reduction interventions. Having developed a systematic process for updating and grading the quality of evidence in the portal, the EMCDDA will take another step forward in 2012, with a new project to identify knowledge gaps and highlight topics for further investigation in this area.
This ‘gap-analysis project’ will proactively garner unanswered questions arising from the day-to-day experiences of decision-makers, practitioners and clients. It will also identify topics for the development of guidelines. The project, which is now in its protocol phase, encompasses a literature review and exploratory interviews with individual practitioners and clients from across Europe. The project will result in a structured overview of available information and recommendations for bridging the identified gaps. Preliminary results will be presented to the EMCDDA Scientific Committee in May.
Enhancing EMCDDA–ESPAD cooperation
Cited from article by Deborah Olszewski in Drugnet Europe, No. 77, January–March 2012
The EMCDDA and the European School Survey Project on Alcohol and Other Drugs (ESPAD) are scaling up their cooperation in monitoring substance use among 15- to 16-year-old school students. Their commitment was underlined in a joint statement adopted at the 2011 ESPAD project meeting, hosted by the EMCDDA in Lisbon (www.emcdda.europa.eu/about/partners/espad)  
ESPAD data provide crucial information on substance use among school students of this age and are routinely included in the EMCDDA’s annual reporting on the drug situation in Europe. In the statement, the partners agreed to boost technical cooperation to enhance understanding of long-term drug use trends in Europe. … Among others, they agreed to: develop an enhanced dissemination strategy for ESPAD findings and work together to ensure harmonisation of methods and support methodological developments. In 2012, the partners will be collaborating, for the second time, in a joint multilingual publishing project to disseminate the key results of the latest ESPAD survey (2011). This summary, in 23 languages, is scheduled to be released before summer.
First European quality standards to improve drug prevention in the EU
Cited from article by Gregor Burkhart in Drugnet Europe, No. 77, January–March 2012
Developing and implementing best practice in drug prevention in Europe are goals set by the current EU drug strategy and action plan. In line with these goals, … [a new EMCDDA] manual is the culmination of a two-year project to assess existing guidance in this area and to meet the need for a commonly agreed European framework to improve drug prevention in the EU. … Bridging science, policy and practice, over 400 international, European and national experts and stakeholders contributed to developing the standards via a dynamic process involving focus groups, consultations and studies. www.emcdda.europa.eu/publications/manuals/prevention-standards
EMCDDA launches new multicity project
Cited from article by Liesbeth Vandam and Ana Gallegos in Drugnet Europe, No. 77, January–March 2012
The EMCDDA has recently launched a multicity ‘demonstration project’ to investigate the potential of wastewater
analysis as an indicator for estimating community drug use levels (www.emcdda.europa.eu/wastewater-analysis). By the end of 2012, the project will have generated comparable data from at least 15 European cities, thanks to an agreed common sampling approach designed to ensure maximum comparability. … By sampling a known source of wastewater – for example, a sewage influent to a wastewater treatment plant – scientists can now obtain estimates of the total quantity of drugs consumed by a community by measuring the levels of illicit drug metabolites excreted in urine. This demonstration project will provide comparable information in real time on weekly patterns of use, trends and changing consumption habits in the participating cities.  
Drugnet Europe is the quarterly newsletter of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Drugs in focus is a series of policy briefings published by the EMCDDA. Both publications are available at www.emcdda.europa.eu.
If you would like a hard copy of the current or future issues of either publication, please contact:
Health Research Board, Knockmaun House, 42–47 Lower Mount Street, Dublin 2. Tel: 01 2345 148; Email: drugnet@hrb.ie
Item Type
Publication Type
International, Open Access, Article
Drug Type
Substances (not alcohol/tobacco)
Issue Title
Issue 41, Spring 2012
April 2012
Page Range
p. 26
Health Research Board
Issue 41, Spring 2012
Accession Number
HRB (Electronic Only)

Repository Staff Only: item control page